Literature DB >> 8091968

Effect of surfactant lavage in a rabbit model of meconium aspiration syndrome.

Y Ohama1, Y Itakura, N Koyama, H Eguchi, Y Ogawa.   

Abstract

Meconium aspiration syndrome (MAS) is a frequent cause of respiratory distress in neonates. Recent reports have suggested that surfactant dysfunction contributes to the pathophysiology of MAS and surfactant therapy improves oxygenation of infants with MAS. We evaluated the effect of bronchial lavage with surfactant solution in a rabbit model of meconium aspiration. All animals were given 5 mL/kg of a 20% slurry of human meconium into the endotracheal tube and mechanically ventilated. The animals were then divided into saline lavage (n = 5) or surfactant lavage (n = 5). Lavage was performed an hour after meconium instillation. After the lavage the total amount of meconium recovered was measured. Blood gas was monitored during the experiment. The amount of meconium recovered by saline lavage was 14%, and by surfactant lavage was 57%. The surfactant group had a significant improvement in gas exchange, whereas the saline group had no improvement. It was concluded that the lavage with surfactant solution effectively washed out meconium and improved gas exchange in rabbit model of MAS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8091968     DOI: 10.1111/j.1442-200x.1994.tb03170.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  3 in total

Review 1.  Surfactant therapy for meconium aspiration syndrome: current status.

Authors:  Peter A Dargaville; John F Mills
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Lavage administration of dilute surfactant in a piglet model of meconium aspiration.

Authors:  Joan Meister; Venkataraman Balaraman; Malia Ramirez; Catherine F T Uyehara; Jeffrey Killeen; Tercia Ku; Donald Person; David Easa
Journal:  Lung       Date:  2004       Impact factor: 2.584

3.  Treatment of severe meconium aspiration syndrome with porcine surfactant. Collaborative Surfactant Study Group.

Authors:  H L Halliday; C P Speer; B Robertson
Journal:  Eur J Pediatr       Date:  1996-12       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.